These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21761023

  • 1. Chondroid hamartoma presenting as solitary pulmonary nodule: results of dual time point (18)F-fluorodeoxyglucose-PET and comparison with (18)F-fluorothymidine PET and histopathology.
    Basu S, Nandy S, Rajan MG, Ramadwar M, Moghe SH.
    Hell J Nucl Med; 2011; 14(2):173-4. PubMed ID: 21761023
    [No Abstract] [Full Text] [Related]

  • 2. Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography.
    De Cicco C, Bellomi M, Bartolomei M, Carbone G, Pelosi G, Veronesi G, De Pas T, Spaggiari L, Paganelli G.
    Ann Thorac Surg; 2008 Dec; 86(6):1769-72. PubMed ID: 19021972
    [Abstract] [Full Text] [Related]

  • 3. Solitary Pulmonary Fibroleiomyomatous Hamartoma on 18 F-FDG PET/CT.
    Tao Y, Wang F, Yan J, Chen Z, He C.
    Clin Nucl Med; 2024 Jan 01; 49(1):81-82. PubMed ID: 37937956
    [Abstract] [Full Text] [Related]

  • 4. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS, Cerfolio RJ.
    Ann Thorac Surg; 2006 Sep 01; 82(3):1016-20. PubMed ID: 16928527
    [Abstract] [Full Text] [Related]

  • 5. [PET-CT in evaluation of pulmonary nodule--case report].
    Zielonka TM, Pietrzykowski J, Wardyn KA.
    Pol Merkur Lekarski; 2009 Aug 01; 27(158):119-22. PubMed ID: 19856877
    [Abstract] [Full Text] [Related]

  • 6. Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient.
    Barešić M, Sreter KB, Brčić L, Hećimović A, Janevski Z, Anić B.
    Lupus; 2015 Dec 01; 24(14):1546-51. PubMed ID: 26085598
    [Abstract] [Full Text] [Related]

  • 7. False-positive FDG positron emission tomography in pulmonary amyloidosis.
    Ollenberger GP, Knight S, Tauro AJ.
    Clin Nucl Med; 2004 Oct 01; 29(10):657-8. PubMed ID: 15365447
    [No Abstract] [Full Text] [Related]

  • 8. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
    Macdonald K, Searle J, Lyburn I.
    Clin Radiol; 2011 Mar 01; 66(3):244-50. PubMed ID: 21295203
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary nodules as incidental findings.
    Simon M, Zukotynski K, Naeger DM.
    CMAJ; 2018 Feb 12; 190(6):E167. PubMed ID: 29440337
    [No Abstract] [Full Text] [Related]

  • 11. Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker.
    Tanaka R, Emerson LL, Karwande SV, Schreiber G.
    Chest; 2005 May 12; 127(5):1848-51. PubMed ID: 15888868
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y, Tateishi U, Uno H, Takeuchi M, Terauchi T, Goya T, Kim EE.
    Ann Nucl Med; 2008 Aug 12; 22(7):571-7. PubMed ID: 18756359
    [Abstract] [Full Text] [Related]

  • 13. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J, Yang X, Yu L, Chen P, Xin J, Ma L, Feng H, Tan Y, Zhao Z, Wu W.
    J Nucl Med; 2008 Feb 12; 49(2):186-94. PubMed ID: 18199618
    [Abstract] [Full Text] [Related]

  • 14. Anthracotic solitary pulmonary nodule imitating lung malignancy on F-18 FDG PET/CT imaging.
    Canbaz F, Kefeli M, Sahin Z, Basoglu T.
    Clin Nucl Med; 2011 Oct 12; 36(10):955-6. PubMed ID: 21892061
    [No Abstract] [Full Text] [Related]

  • 15. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia.
    Shin L, Katz DS, Yung E.
    Clin Nucl Med; 2004 Oct 12; 29(10):654-6. PubMed ID: 15365446
    [No Abstract] [Full Text] [Related]

  • 16. PET evaluation of lung cancer.
    Bunyaviroch T, Coleman RE.
    J Nucl Med; 2006 Mar 12; 47(3):451-69. PubMed ID: 16513615
    [No Abstract] [Full Text] [Related]

  • 17. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR.
    Chest; 2007 Jan 12; 131(1):255-60. PubMed ID: 17218584
    [Abstract] [Full Text] [Related]

  • 18. Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
    Himpe U, Deroose CM, Leyn PD, Verbeken E, Vansteenkiste J.
    J Thorac Oncol; 2009 Jan 12; 4(1):107-8. PubMed ID: 19096317
    [Abstract] [Full Text] [Related]

  • 19. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G.
    J Natl Cancer Inst; 2007 Dec 05; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract] [Full Text] [Related]

  • 20. PET for the evaluation of solitary pulmonary nodules.
    Fisher RE.
    J Nucl Med; 2009 Feb 05; 50(2):326; author reply 326-7. PubMed ID: 19164230
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.